Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
OctoPlus
OctoPlus
Activities:
Manufacturing
Drug Delivery
Pharmaceutical
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Drug Delivery
Dr. Reddy’s Laboratories to acquire OctoPlus for €27.4m
Aims to build a research base in Leiden, The Netherlands
Manufacturing
OctoPlus signs agreement with pharma company to develop controlled release formulation
Of a therapeutic compound for local delivery into joints
Manufacturing
Octoplus extends drug delivery contract with Top-5 pharma company
Will combine product candidate with Octoplus PolyActive drug delivery technology
Research & Development
OctoPlus extends development agreement with ESBATech
For controlled release product for ophthalmic indications
Drug Delivery
OctoPlus appoints ceo
Jan Hendrik Egberts to replace Simon Sturge
Drug Delivery
OctoPlus signs controlled release technology deal with US firm
Will use PolyActive technology to develop compound
Drug Delivery
OctoPlus wins drug delivery contract expansion
Client will proceed with PolyActive technology evaluation
Subscribe now